Zidovudine
- TRADE NAMES: Combivir (ViiV); Novo-AZT; Retrovir (ViiV); Trizivir (ViiV)
- INDICATIONS: HIV infection
- SYNONYM: azidothymidine; AZT
- CLASS: Antiretroviral, Nucleoside analog reverse transcriptase inhibitor
- HALF-LIFE: 0.5–3 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Atovaquone, Bone marrow suppressives, Clarithromycin, Darunavir, Diclofenac, Doxorubicin, Fluconazole, Ganciclovir, Indinavir, Interferon Alfa, Interferon Beta, Lopinavir, Meloxicam, Methadone, NSAIDs, PEG-Interferon, Phenytoin, Probenecid, Pyrimethamine, Ribavirin, Rifampin, Rifapentine, Stavudine, Tipranavir, Valproic Acid
PREGNANCY CATEGORY: C
Combivir is zidovudine and lamivudine; Trizivir is zidovudine, abacavir and lamivudine.
HEMATOLOGICAL TOXICITY, MYOPATHY, LACTIC ACIDOSIS AND SEVERE HEPATOMEGALY, and EXACERBATIONS OF HEPATITIS B
See full prescribing information for complete boxed warning.
Please login to see the rest of this drug profile
SKIN.
HAIR.
NAILS.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
HEMATOLOGIC.
NEUROMUSCULAR/SKELETAL.
OCULAR.
RENAL.
OTHER.
Page last updated 07/31/2023
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric